Scott Vold

Scott Vold holds a distinguished career with extensive experience in leadership and advisory roles across various companies, currently serving as Chief Commercial Officer at Renalogic and as an Advisor at Redesign Health. As a Venture Partner at Radian Capital, Scott invests in growth-stage technology and software businesses. Prior roles include Vice President at Cerner, where Scott drove the global expansion of the HealtheReferrals business, and Chief Executive Officer of Fibroblast, leading the company from its inception to acquisition by Cerner. Scott's earlier career includes litigation roles at prestigious law firms and participating in the 2012 Excelerate Labs startup accelerator. Scott Vold earned a JD from Washington University in St. Louis and a BA in Philosophy and Political Science from the University of Illinois Urbana-Champaign.